Swiss stocks - Factors to watch on April 20



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Swiss stocks - Factors to watch on April 20</title></head><body>

ZURICH/BERLIN, April 20 (Reuters) -Here are some of the main factors that may affect Swiss stocks on Thursday:


CREDIT SUISSE CSGN.S

Credit Suisse has lodged a $440 million claim against Japan's SoftBank Group Corp 9984.T in London as it presses ahead with formal proceedings in a dispute borne from the failure of Greensill Capital, a finance firm.

Separately, Credit Suisse Group AG's dealmakers, hoping to secure jobs after UBS Group AG's UBSG.S rescue takeover, are struggling to dispel fears about a culture clash and many will be disappointed, sources familiar with the talks told Reuters.

And Bloomberg News reported Credit Suisse veteran banker Alois Mueller is retiring from the lender.

Separately, the FT reported that Singapore bondholders are preparing to sue Switzerland over the Credit Suisse case.


SWISS NATIONAL BANK SNBN.S

Swiss inflation may be low compared to other countries but is still too high, Swiss National Bank Vice Chairman Martin Schlegel said on Wednesday, hinting at possible further interest rates ahead.


NESTLE NESN.S

Nestle investors warn of 'systemic risks' from unhealthy foods, reported the Financial Times.


SIKA SIKA.S

Australia's competition regulator said it would not oppose Sika's 5.5 billion Swiss franc ($6.12 billion) takeover of MBCC Group, only if the Swiss chemicals maker divested MBCC Group's entire business in Australia and New Zealand.


NOVARTIS NOVN.S

Amgen Inc AMGN.O convinced a U.S. appeals court on Wednesday to uphold patents that bar generic versions of its blockbuster psoriasis drug Otezla proposed by Zydus Pharmaceuticals ZYDU.NS and Novartis AG's Sandoz Inc until 2028.


ROCHE ROG.S

Roche said the U.S. FDA approved Polivy in combination with R-CHP for people with certain types of previously untreated diffuse large B-cell lymphoma.


SCHINDLER HOLDING SCHP.S

Schindler Holding reported first-quarter earnings before interest and taxes (EBIT) of 282 million Swiss francs ($314.45 million).


COMPANY STATEMENTS

* Achiko AG ACHIN.S said it continues to struggle to connect production to sales in Indonesia. ACHIN.S

*Peace Property Group AG PEAN.S announced Chief Executive Thomas Wolfensberger has resigned. PEAN.S



EX-DIVIDEND

TECAN TECN.S - 2.90 CHF/shr dividend



ECONOMY

No major Swiss economic data scheduled.



($1 = 0.8968 Swiss francs)



Reporting by Zurich newsroom and Berlin Speed Desk

For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g

FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German .SDE
All SMI constituent stocks 0#.SSMI
DJ STOXX index .STOXX
Top 10 STOXX sectors .PGL.STOXXS
Top 10 EUROSTOXX sectors .PGL.STOXXES

Swiss mid-cap index .SSMI
Swiss all-share index .SSHI
Swiss market digest .AD.S
Sector overview CH/SECTOR1
All Swiss news CH
Swiss research news CH-RCH
All equity news E

SPEED GUIDES: EQUITY, EQUITY/NEWS1, EUR/EQUITY, SWITZERLAND, REUTERS
</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.